Account
An experimental Roche drug that seems to work particularly well against lung cancer in smokers may be a "game changer" for these normally difficult-to-treat patients, researchers said on Sunday.Presenting detailed data from an early-stage trial of the drug, called MPDL3280A, in patients with a form of the disease called non-small cell lung cancer (NSCLC), investigators said what they had found was "great news for lung cancer patients".Of 53 patients with NSCLC tumours treated with the drug, 23 percent saw their tumours shrink, according to results presented at the European Cancer Congress (ECC) in Amsterdam.But the most encouraging numbers were among smokers, where the response rate was 26 percent compared with 10 percent of patients who had never smoked, said Professor Jean-Charles Soria of France's Institut Gustave Roussy, who led the study.Lung cancer, which is usually caused by smoking, is extremely difficult to treat successfully and once it has started to spread to other parts of...
Oncolytics Biotech (NASDAQ:ONCY) said Monday its experimental drug Reolysin shrunk lung cancer tumors in 92% of patients in a mid-stage study.On average, tumors were...
The Bush administration has decided to defend rules from the Clinton era making it easier for coal miners suffering from black-lung disease to get benefits.The coal ...
What's killing us? For decades, global health leaders have focused on diseases that can spread — AIDS, tuberculosis , new flu bugs. They pushed for vaccines , better...
Female smokers are more likely to die from lung cancer now than a few decades ago, a new study says.In the 1960s, female smokers were 2.7 times more likely to di...
Last year flu came early and came hard, hospitalizing the most elderly patients on record and killing 161 children.This year the National Foundation of Infectious Di...
More Americans are getting vaccinated against the flu, but there is still room for improvement, public health officials said today.During last year's (2012-2013) par...
Seems like all the really fun stuff causes cancer. But sometimes, you can indulge. We break down your bad habits (bacon's just the beginning).Bad habit: Your morning...
A drug available in Europe called roflumilast helps ease symptoms of chronic obstructive pulmonary disease (COPD), researchers report in The Lancet.COPD is an inflam...
A biotech drug from Roche has become the first medicine approved to treat breast cancer before surgery, offering an earlier approach against one of the deadliest for...
Some fans of "Breaking Bad," the AMC series which concluded Sunday night, were inspired to place an obituary for character Walter White in the Albuquerque Journal.Th...
Health officials are embarking on an ambitious plan to wipe out tuberculosis in children worldwide, even though they don't know exactly how many cases there are.Expe...
Former U.S. Rep. E. Clay Shaw has died following a lengthy battle against lung cancer. He was 74.Shaw's family says in a statement that he died Tuesday night at Holy...
Researchers have discovered a class of FDA-approved antidepressants that may prove effective in treating patients with small-cell lung cancer – one of the deadliest ...
German drugmaker Merck KGaA will conduct new tests on an experimental lung cancer vaccine which failed a previous late-stage clinical trial, it said on Wednesday.Mer...
Emphysema, one of several diseases collectively known as common obstructive pulmonary disease, is a long-term, progressive illness and one of the most common lung di...
People with emphysema or chronic bronchitis may be at higher than average risk for a painful rash known as shingles, a study published Tuesday suggests.The shingles ...
Experts answer common questions about vaccines for children and adults. 1. How Do Vaccines Work? When you get sick, your body creates special proteins called antibod...
Fight against cancer gets new help from old friend
Bacteria are often social creatures. Suspended in colonies of varying shapes and sizes, these microbes communicate with their brethren and even other bacterial speci...